Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
COZ.DE Stock Summary
Top 10 Correlated ETFs
COZ.DE
In the News
COZ.DE Financial details
Company Rating
Buy
Market Cap
32.36B
Income
2.13B
Revenue
19.35B
Book val./share
26.45
Cash/share
5.27
Dividend
0.27
Dividend %
0.39%
Employees
347.7K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
18.57
Forward P/E
-
PEG
-47.52
P/S
1.92
P/B
3.01
P/C
11.97
P/FCF
19.02
Quick Ratio
1.94
Current Ratio
2.23
Debt / Equity
0.1
LT Debt / Equity
-
-
-
EPS (TTM)
4.18
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
2.89%
Revenue Q/Q
-2.84%
EPS Q/Q
7.69%
-
-
-
-
SMA20
-5.8%
SMA50
-9.72%
SMA100
1.56%
Inst Own
-
Inst Trans
-
ROA
12%
ROE
16%
ROC
0.18%
Gross Margin
34%
Oper. Margin
14%
Profit Margin
11%
Payout
28%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
65-66.07
52W High
-4.41%
52W Low
-2.94%
RSI
30
Rel Volume
3.26
Avg Volume
70
Volume
228
Perf Week
-3.03%
Perf Month
-10.23%
Perf Quarter
5.19%
Perf Half Y
-0.57%
-
-
-
-
Beta
1.066
-
-
Volatility
0.95%, 2.34%
Prev Close
-0.19%
Price
63.09
Change
-0.35%
COZ.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 30.02 | 30.84 | 35.12 | 37.51 | 0 | |
Net income per share | 3.3 | 2.58 | 4.06 | 4.42 | 0 | |
Operating cash flow per share | 4.47 | 6.11 | 4.73 | 4.96 | 0 | |
Free cash flow per share | 3.77 | 5.37 | 4.2 | 4.32 | 0 | |
Cash per share | 6.13 | 5.04 | 5.16 | 4.83 | 0 | |
Book value per share | 19.72 | 20.07 | 22.75 | 23.76 | 0 | |
Tangible book value per share | 10.74 | 8.81 | 9.78 | 10.48 | 0 | |
Share holders equity per share | 19.72 | 20.07 | 22.75 | 23.76 | 0 | |
Interest debt per share | 3.06 | 3.3 | 3.13 | 3 | 0 | |
Market cap | 34.85B | 43.72B | 47.28B | 29.35B | 0 | |
Enterprise value | 33.89B | 42.8B | 47.13B | 28.69B | -1.31B | |
P/E ratio | 18.92 | 31.41 | 22.12 | 12.81 | 0 | |
Price to sales ratio | 2.08 | 2.63 | 2.55 | 1.51 | 0 | |
POCF ratio | 13.95 | 13.25 | 18.95 | 11.43 | 0 | |
PFCF ratio | 16.54 | 15.07 | 21.34 | 13.12 | 0 | |
P/B Ratio | 3.16 | 4.03 | 3.94 | 2.38 | 0 | |
PTB ratio | 3.16 | 4.03 | 3.94 | 2.38 | 0 | |
EV to sales | 2.02 | 2.57 | 2.55 | 1.48 | -0.07 | |
Enterprise value over EBITDA | 10.09 | 14.25 | 13.74 | 7.98 | -0.36 | |
EV to operating cash flow | 13.56 | 12.97 | 18.89 | 11.17 | -0.56 | |
EV to free cash flow | 16.09 | 14.75 | 21.27 | 12.83 | -0.65 | |
Earnings yield | 0.05 | 0.03 | 0.05 | 0.08 | 0 | |
Free cash flow yield | 0.06 | 0.07 | 0.05 | 0.08 | 0 | |
Debt to equity | 0.15 | 0.16 | 0.14 | 0.12 | 0.1 | |
Debt to assets | 0.1 | 0.1 | 0.09 | 0.09 | 0.07 | |
Net debt to EBITDA | -0.29 | -0.31 | -0.04 | -0.18 | -0.36 | |
Current ratio | 2.55 | 1.94 | 2.08 | 2.17 | 2.25 | |
Interest coverage | 94.35 | 88.08 | 314 | 156.21 | 65.59 | |
Income quality | 1.36 | 2.37 | 1.17 | 1.12 | 1.1 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.02 | 0 | |
Payout ratio | 0.25 | 0.34 | 0.24 | 0.25 | 0.28 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.31 | 0.36 | 0.38 | 0.39 | 0.39 | |
Capex to operating cash flow | -0.16 | -0.12 | -0.11 | -0.13 | -0.14 | |
Capex to revenue | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | |
Capex to depreciation | -0.75 | -0.71 | -0.49 | -0.58 | -0.57 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 38.23 | 34.12 | 45.56 | 48.62 | 0 | |
ROIC | 0.13 | 0.1 | 0.15 | 0.15 | 0.13 | |
Return on tangible assets | 0.16 | 0.13 | 0.19 | 0.21 | 0.19 | |
Graham Net | 1.22 | -1.94 | -0.9 | -0.38 | 0 | |
Working capital | 4.63B | 3.31B | 3.81B | 3.92B | 4.17B | |
Tangible asset value | 6B | 4.76B | 5.15B | 5.43B | 5.99B | |
Net current asset value | 2.43B | 764M | 1.48B | 1.72B | 2.25B | |
Invested capital | 0.15 | 0.16 | 0.14 | 0.12 | 0.1 | |
Average receivables | 3.26B | 3.17B | 3.32B | 3.68B | 3.82B | |
Average payables | 227M | 314M | 375M | 360.5M | 348.5M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 70.81 | 67.66 | 70.15 | 71.32 | 72.59 | |
Days payables outstanding | 8.2 | 13.31 | 11.36 | 10.56 | 9.71 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 5.15 | 5.39 | 5.2 | 5.12 | 5.03 | |
Payables turnover | 44.49 | 27.43 | 32.14 | 34.58 | 37.58 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.17 | 0.13 | 0.18 | 0.19 | 0.16 | |
Capex per share | -0.7 | -0.74 | -0.53 | -0.64 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.45 | 9.45 | 9.66 | 9.72 | 9.52 | |
Net income per share | 1.02 | 1.14 | 0.92 | 1.04 | 1.12 | |
Operating cash flow per share | 1.37 | 1.43 | 0.07 | 1.64 | 1.47 | |
Free cash flow per share | 1.2 | 1.24 | -0.06 | 1.5 | 1.32 | |
Cash per share | 4.88 | 4.87 | 4.14 | 4.7 | 5.27 | |
Book value per share | 24.04 | 24.87 | 25.5 | 25.56 | 26.45 | |
Tangible book value per share | 10.61 | 10.53 | 11.09 | 11.3 | 11.98 | |
Share holders equity per share | 24.04 | 24.87 | 25.5 | 25.56 | 26.45 | |
Interest debt per share | 3.01 | 2.98 | 2.95 | 2.89 | 2.65 | |
Market cap | 29.01B | 31.02B | 33.1B | 34.28B | 37.34B | |
Enterprise value | 28.35B | 30.07B | 32.52B | 33.52B | 36.03B | |
P/E ratio | 13.92 | 13.37 | 17.87 | 16.32 | 16.73 | |
Price to sales ratio | 5.99 | 6.45 | 6.77 | 7 | 7.85 | |
POCF ratio | 41.32 | 42.55 | 919.39 | 41.4 | 50.66 | |
PFCF ratio | 47.39 | 49.15 | -1.03K | 45.4 | 56.66 | |
P/B Ratio | 2.36 | 2.45 | 2.57 | 2.66 | 2.82 | |
PTB ratio | 2.36 | 2.45 | 2.57 | 2.66 | 2.82 | |
EV to sales | 5.86 | 6.25 | 6.66 | 6.84 | 7.57 | |
Enterprise value over EBITDA | 33.16 | 34.68 | 38.08 | 36.24 | 38.45 | |
EV to operating cash flow | 40.38 | 41.24 | 903.44 | 40.48 | 48.89 | |
EV to free cash flow | 46.32 | 47.65 | -1.02K | 44.39 | 54.68 | |
Earnings yield | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | 0.02 | 0.02 | 0 | 0.02 | 0.02 | |
Debt to equity | 0.12 | 0.12 | 0.11 | 0.11 | 0.1 | |
Debt to assets | 0.09 | 0.08 | 0.08 | 0.08 | 0.07 | |
Net debt to EBITDA | -0.77 | -1.1 | -0.67 | -0.82 | -1.39 | |
Current ratio | 2.17 | 2.18 | 2.27 | 2.23 | 2.25 | |
Interest coverage | 85.75 | 78 | 57.7 | 62.36 | 65.82 | |
Income quality | 1.35 | 1.26 | 0.08 | 1.58 | 1.32 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.27 | 0.26 | 0.32 | 0.28 | 0.26 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.39 | 0.4 | 0.41 | 0.4 | 0.39 | |
Capex to operating cash flow | -0.13 | -0.13 | -1.89 | -0.09 | -0.11 | |
Capex to revenue | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 | |
Capex to depreciation | -0.64 | -0.74 | -0.48 | -0.5 | -0.57 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 23.46 | 25.25 | 22.91 | 24.48 | 25.77 | |
ROIC | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 | |
Return on tangible assets | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | |
Graham Net | -0.38 | -0.43 | -0.3 | 0.05 | 0.53 | |
Working capital | 3.92B | 3.91B | 3.9B | 3.94B | 4.17B | |
Tangible asset value | 5.43B | 5.36B | 5.61B | 5.7B | 5.99B | |
Net current asset value | 1.72B | 1.74B | 1.89B | 1.93B | 2.25B | |
Invested capital | 0.12 | 0.12 | 0.11 | 0.11 | 0.1 | |
Average receivables | 3.74B | 3.76B | 3.74B | 3.78B | 3.83B | |
Average payables | 363.5M | 346M | 325M | 321.5M | 331M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 70.6 | 69.54 | 69.17 | 69.97 | 72.81 | |
Days payables outstanding | 10.28 | 9.51 | 8.86 | 9.11 | 9.84 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.27 | 1.29 | 1.3 | 1.29 | 1.24 | |
Payables turnover | 8.76 | 9.47 | 10.16 | 9.87 | 9.14 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | |
Capex per share | -0.18 | -0.19 | -0.13 | -0.14 | -0.16 |
COZ.DE Frequently Asked Questions
What is Cognizant Technology Solutions Corporation stock symbol ?
Cognizant Technology Solutions Corporation is a US stock , located in Teaneck of Nj and trading under the symbol COZ.DE
What is Cognizant Technology Solutions Corporation stock quote today ?
Cognizant Technology Solutions Corporation stock price is $63.09 today.
Is Cognizant Technology Solutions Corporation stock public?
Yes, Cognizant Technology Solutions Corporation is a publicly traded company.